Leibniz Institute for Immunotherapy

lit.eu
+49 941 94438100

Leibniz-Institut für Immuntherapie (LIT)

Franz-Josef-Strauß-Allee 11
93053 Regensburg
Germany
+49 941 94438100
lit.eu
Profile News

About Leibniz Institute for Immunotherapy

The Leibniz Institute for Immunotherapy has a clear mission to develop innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation by reprogramming immune cells through synthetic and pharmacological strategies.

Read more about Leibniz Institute for Immunotherapy
Facts about Leibniz Institute for Immunotherapy
  • Employees: 51-200
  • Industry : Biology, Biotechnology, Healthcare

News about Leibniz Institute for Immunotherapy

Leibniz Institute for Immunotherapy

17-Sep-2024 | science

Leveraging intercellular mitochondria transfer to boost cancer immunotherapies

A new cancer busting platform

Read news
Leibniz Institute for Immunotherapy

15-Aug-2024 | science

Unmasking Hidden Potential: LMO4 Enhances T Cell Cancer-Fighting Abilities

Researchers have engineered CD8+ T cells to artificially express the gene LMO4, thereby enhancing their effectiveness against tumors.

Read news
Leibniz Institute for Immunotherapy

29-Jul-2024 | science

‘Jumping Genes’ Support Immune Cells in Tissue

Researchers at the Leibniz Institute for Immunotherapy (LIT) describe a new type of regulation of immune cells by so-called 'jumping genes'

Read news
Leibniz Institute for Immunotherapy

19-Jan-2024 | science

Killer T Cells Support Tissue Regeneration

Which factors mediate this surprising healing property?

Read news
Show more news about Leibniz Institute for Immunotherapy

Here you will find Leibniz-Institut für Immuntherapie (LIT)